PubMed HealthSearch

PubMed · 3208504

Workflow analysis in determining instrumentation needs.

Abstract

The workflow parameters that have been reviewed should be carefully utilized with all the other traditional evaluation techniques in making an instrument decision. Most laboratory managers make the mistake of purchasing a larger analyzer than is required. The cost of this mistake is not just the usually higher purchase price. Larger and higher speed instruments tend to be more complex, requiring better-trained operators and necessitating more maintenance. In addition, they tend to be less flexible for meeting STAT needs and more difficult to bring out of the stand-by mode. For the smaller laboratory, the oversized analyzer not only raises the operating requirements, but potentially lowers the service capabilities. A careful analysis of the laboratory's workflow and production issues may also do more than help clarify the instrumentation issues. Often an audit of how work is processed will uncover new ways to organize and perform the testing. Instead of a new analyzer solving the perceived problem, the solution that has the most impact may not involve any capital acquisition at all. However, even when the decision reached results in new instrumentation, a better understanding of how the new machine should function in the laboratory's environment will only improve its effectiveness in addressing the need.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P T Hirsch. 1988. Workflow analysis in determining instrumentation needs.. https://pubmed.ncbi.nlm.nih.gov/3208504/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An impact assessment of the European medical device regulations implementation - the current status quo.

BACKGROUND: This research aims to assess the current impact of the medical and in-vitro diagnostic devices regulations (MDR/IVDR) on the device industry in the EU, under the lens of postimplementation and the amending regulation, and in advance of the final transition to the IVDR/MDR in the future. RESEARCH DESIGN AND METHODS: A quantitative survey was administered to a diverse cohort of medical device enterprises, ranging from micro to large organizations. RESULTS: The survey indicates that the MDR/IVDR has harmed innovation, leading many manufacturers to seek initial device approval and launch elsewhere before in Europe. There is evidence that some manufacturers have rationalized their existing product portfolios and removed devices from the market as they stated they would in previous industry surveys. The MDR/IVDR has been shown to negatively impact manufacturers, with increased costs related to notified body (NB) fees, maintaining and updating documentation, recertification fees, and hiring additional staff. CONCLUSION: This study provides a current status of the effects of MDR/IVDR on manufacturers and finds that despite amending regulations and other interventions taken by the EU to mitigate regulatory burden, ensure product availability, and address stakeholder concerns, the EU is no longer the market of choice for new products.

Equipment and Supplies